ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
GeneDx at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
GeneDx brings 8 presentations to ASHG 2026 in Montréal, and exhibits at Booth 616. Its ASHG 2026 program centres on rare disease diagnosis, clinical genetics, and reproductive and prenatal testing. GeneDx presents newborn screening results across diverse ancestries, autism exome findings from more than 68,000 individuals, and genotype-first reanalysis of RNU4-2 variants.
| Organization | ASHG 2026 Attendance |
|---|---|
GeneDx Stamford, Connecticut | 1 Senior Vice President of Medical Affairs · 1 Senior Health Economics & Outcomes Research Scientist · 1 Clinical Data Scientist · 1 Senior Genetic Counselor |
GeneDx sells clinical exome and genome testing, clinical interpretation, and genomic insights. It serves healthcare providers and biopharma partners.
| Booth Exhibiting at Booth 616 Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm Talk Wed Oct 21 11:15 am Genomic newborn screening across diverse genetic ancestries: GUARDIAN screen‑positive rates and variant findings among >19,000 newborns Genetic testingLaboratory genetics and genomicsNewborn screening Talk Wed Oct 21 1:39 pm Real-world prevalence of clinically significant RNU4-2 variants and the value of genotype-first reanalysis DiagnosticsExome/genome sequencingNeurodevelopmentalNon-coding RNA Poster Wed Oct 21 2:30 pm Budget Impact Analysis of Adopting First-Line Exome/Genome Sequencing Policy For Pediatric Commercially Insured Patients with Neurologic Disorders: A SAVES-Kids Study Policy issuesExome/genome sequencingEpilepsyIntellectual and developmental disability Talk Thu Oct 22 9:15 am Continuous clinical prioritization of copy number variants (CNVs) through dynamic feature reconstruction Rare variantsCopy number/structural variationGenetic testingMachine learning Talk Thu Oct 22 1:30 pm Factors influencing molecular diagnostic yield in a clinical autism exome sequencing cohort of over 68,000 individuals AutismExome/genome sequencingIdentification of disease genesLaboratory genetics and genomics Poster Fri Oct 23 2:30 pm Leveraging longitudinal real-world data to characterize seizure phenotypes in CSNK2A1-related disorder Characterization of disordersElectronic health recordsEpilepsyGenotype-phenotype correlations Poster Fri Oct 23 2:30 pm ★ Reviewers’ Choice Real-world prevalence of clinically significant RNU4-2 variants and the value of genotype-first reanalysisDiagnosticsExome/genome sequencingNeurodevelopmentalNon-coding RNA Poster Fri Oct 23 2:30 pm AI-assisted phenotype gestalts from 188,132 individuals inform diagnostic yield and reimbursement rate Artificial intelligenceExome/genome sequencingLaboratory genetics and genomicsPhenotype |
Find decision makers at GeneDx
Tell us what you sell and we’ll find the people at GeneDx most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction